Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)

First Patient Receives New Shield Surface Modification, An Advance in Flow Diversion Therapy, at NYU Langone Health DUBLIN, April 21, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, t... Devices, Interventional, FDA Medtronic, Pipeline Flex Embolization Device, aneurysm
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news